R D
-
Merck donates five mobile compact labs for detecting counterfeit medicines to Zambia
To help improve health care in Zambia, the Global Pharma Health Fund, a charitable initiative funded by Merck, has donated five mobile compact laboratories to the Health Ministry in the capital city of Lusaka to help detect counterfeit medicines.
R D | 24 April 2012
-
Phase III studies with VEGF Trap-Eye in wet age-related macular degeneration show sustained improvement in visual acuity
Bayer HealthCare and Regeneron Pharmaceuticals announced that in an integrated analysis of two parallel Phase III studies (VIEW 1 and VIEW 2) in patients with the neovascular form of age-related macular degeneration (wet AMD), patients treated with VEGF Trap-Eye showed a sustained improvement in visual acuity at 96 weeks versus baseline.
R D | 25 January 2012
-
ViroMed receives approval for Phase II trial in the US for diabetic peripheral neuropathy
ViroMed announced that VM202-DPN, the company's proprietary DNA medicine for treatment of diabetic peripheral neuropathy, has received approval from the US FDA for a Phase II clinical trial.
R D | 04 January 2012
-
ICON Development Solutions appoints general manager of Asia Pacific
ICON announced that its development solutions division has appointed Dr Daniel Tang as general manager, Asia Pacific. Dr Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with key opinion leaders for early phase clinical testing.
R D | 12 December 2011
-
Ziopharm Oncology presents preclinical data for Darinaparsin at AACR-NCI-EORTC meeting
Ziopharm Oncology announced that results from preclinical studies of darinaparsin (Zinapar or ZIO-101), a novel organic arsenic, in prostate cancer were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. In addition to company authors, the studies included authors Joseph R Bertino MD and Nitu Bansal PhD from UMDNJ-The Cancer Institute of New Jersey.
R D | 23 November 2011
-
Sanofi chooses Burgopak slider design for heartburn treatment
Sanofi has chosen the award-winning Burgopak slider design for its heartburn treatment, Maalox Plus, which was launched into the Italian market this year.
R D | 31 October 2011
-
Bristol-Myers Squibb and Saladax Biomedical expand collaboration for diagnostic assays for Alzheimer’s disease
Companies will collaborate globally on the development and regulatory approvals for certain diagnostic assays.
R D | 20 September 2011
-
Sanofi Pasteur donates vaccine strain used for polio eradication to WHO
Vaccine strain used in the production of oral polio vaccines against type 3 poliovirus.
R D | 20 September 2011
-
The other drug problem
There is a new front in the war on drugs, and it's not the kind of drugs one might think.
R D | 01 September 2011
-
PBS Biotech selects GCMS as exclusive bioreactor distributor in Korea
PBS Biotech Inc announced it has signed an exclusive distribution agreement in Korea with Green Cross Medical Sciences Corp (GCMS), one of Korea’s largest pharmaceutical firms. Under terms of the agreement GCMS will market, sell and support the com…
R D | 27 July 2011
